Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Photocure ASA ( (PHCUF) ).
Photocure ASA has appointed Jane Healy as Vice President and General Manager EMEA to lead its European Organization. With extensive experience in the medical device field, Healy’s leadership is expected to drive growth and innovation in the uro-oncology sector, enhancing the company’s market position and improving patient outcomes in bladder cancer treatment.
More about Photocure ASA
Photocure ASA, known as The Bladder Cancer Company, specializes in providing transformative solutions for bladder cancer patients. The company is headquartered in Oslo, Norway, and is listed on the Oslo Stock Exchange. Photocure’s unique technology enhances the detection of cancer cells, improving health outcomes globally. They commercialize their products directly in the U.S. and Europe and have strategic partnerships in other regions.
YTD Price Performance: -18.80%
Average Trading Volume: 484
Technical Sentiment Signal: Strong Buy
Current Market Cap: $150.6M
For an in-depth examination of PHCUF stock, go to TipRanks’ Stock Analysis page.